| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 1398245 | European Journal of Medicinal Chemistry | 2006 | 5 Pages |
A series of novel 4-(E)-ethenyl-6-alkylamino-1,3,5-triazin-2-ylamine derivatives 9–17 have been synthesized by a Wittig reaction of corresponding alkyltriphenylphosphonium bromides 5–8 with (hetero)aromatic aldehydes. The E configuration of these alkenes was confirmed by 1H NMR spectroscopic data. All the compounds prepared were screened at the National Cancer Institute (NCI) for their activity against a panel of 56 tumor cell lines and relationship between structure and in vitro antitumor activity is discussed. The most active compounds 14 and 17 showed 50% growth inhibitory activity in low micromolar concentrations against renal cancer A498 cell line and colon cancer cell line COLO 205, respectively.
Graphical abstractFigure optionsDownload full-size imageDownload as PowerPoint slide
